[{"address1": "11711 N. Meridian Street", "address2": "Suite 300", "city": "Carmel", "state": "IN", "zip": "46032", "country": "United States", "phone": "(317) 659-0200", "website": "https://mbxbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.", "fullTimeEmployees": 38, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Kent Hawryluk MBA", "age": 55, "title": "CEO, President & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 571200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard B. Bartram CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 578000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven J. Prestrelski M.B.A., MBA, Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Gambino", "title": "Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Graham", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Salomon  Azoulay M.D.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Dorato DABT, Ph.D.", "title": "Sr. Vice President of Discovery & Non-Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.63, "open": 8.63, "dayLow": 8.58, "dayHigh": 9.48, "regularMarketPreviousClose": 8.63, "regularMarketOpen": 8.63, "regularMarketDayLow": 8.58, "regularMarketDayHigh": 9.48, "payoutRatio": 0.0, "forwardPE": -3.7339056, "volume": 159770, "regularMarketVolume": 159770, "averageVolume": 307526, "averageVolume10days": 199410, "averageDailyVolume10Day": 199410, "bid": 8.74, "ask": 9.16, "bidSize": 1, "askSize": 1, "marketCap": 290731360, "fiftyTwoWeekLow": 8.54, "fiftyTwoWeekHigh": 27.5, "fiftyDayAverage": 11.3014, "twoHundredDayAverage": 17.48128, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13878537, "profitMargins": 0.0, "floatShares": 13610914, "sharesOutstanding": 33417400, "sharesShort": 4109163, "sharesShortPriorMonth": 2799627, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.123, "heldPercentInsiders": 0.03243, "heldPercentInstitutions": 0.98632, "shortRatio": 14.0, "impliedSharesOutstanding": 33417400, "bookValue": 8.131, "priceToBook": 1.0699791, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -55179000, "trailingEps": -1.65, "forwardEps": -2.33, "enterpriseToEbitda": -0.234, "52WeekChange": -0.6321353, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 8.7, "targetHighPrice": 44.0, "targetLowPrice": 30.0, "targetMeanPrice": 37.25, "targetMedianPrice": 37.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 277063008, "totalCashPerShare": 8.291, "ebitda": -59348000, "totalDebt": 210000, "quickRatio": 25.451, "currentRatio": 25.748, "debtToEquity": 0.077, "operatingCashflow": -49790000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "MBX Biosciences, Inc.", "shortName": "MBX Biosciences, Inc.", "exchange": "NMS", "messageBoardId": "finmb_613097171", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1741982707, "regularMarketTime": 1741982401, "regularMarketChangePercent": 0.8111204, "regularMarketPrice": 8.7, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.65, "epsForward": -2.33, "epsCurrentYear": -13.24512, "priceEpsCurrentYear": -0.6568457, "fiftyDayAverageChange": -2.6014004, "fiftyDayAverageChangePercent": -0.2301839, "twoHundredDayAverageChange": -8.78128, "twoHundredDayAverageChangePercent": -0.50232476, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 8.7, "postMarketChange": 0.0, "regularMarketChange": 0.069999695, "regularMarketDayRange": "8.58 - 9.48", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 307526, "fiftyTwoWeekLowChange": 0.15999985, "fiftyTwoWeekLowChangePercent": 0.018735345, "fiftyTwoWeekRange": "8.54 - 27.5", "fiftyTwoWeekHighChange": -18.8, "fiftyTwoWeekHighChangePercent": -0.6836363, "fiftyTwoWeekChangePercent": -63.213528, "earningsTimestampStart": 1730984403, "earningsTimestampEnd": 1730984403, "displayName": "MBX Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]